Thread regarding Sanofi-Aventis layoffs

Framingham - Streamlining its processes + adjusting staffing levels (read layoffs)

Sanofi Genzyme is a leader in life sciences, focusing on the development of the treatment for rare diseases. According to media sources, Sanofi Genzyme has indicated that it is investing more than $300 million into the Framingham facility and technology; streamlining its processes and adjusting staffing levels. Sanofi Genzyme has expressed its commitment to the City of Framingham

| 1349 views | | no replies yet
Post ID: @OP+TabUsbC

There are no replies in this thread yet. Be the first to post a reply below:

Post a reply